Jobs @ Immatics Munich

Join Our Team in Munich

Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. We are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer.

Immatics’ fundamental purpose is to apply its technology and drug development efforts toward improving outcomes for the scores of cancer patients who have not yet benefitted from the exciting advances of using the immune system to fight the disease.

From its research and development origins in Tübingen, Germany, to its cell therapy center in Houston, Texas, Immatics represents a trans-Atlantic team united towards becoming a global leader in T cell receptor-based immunotherapies.

We are seeking talented and committed people to join our R&D, commercial and regulatory teams in Tübingen and Munich.

What We Offer

We are an equal opportunity employer, offering a competitive base salary and benefits package including a share option and childcare support programs.

We offer flexible working hours, foster work-life balance and encourage career development for all our employees.

Available Jobs

We are only accepting digital applications via email to our official address: For all other applications we cannot guarantee the protection of your private data.

Wir suchen zum nächstmöglichen Zeitpunkt in Vollzeit eine/n |Manager Regulatory Affairs CMC zur Verstärkung unseres Regulatory Affairs Teams am Standort Tübingen oder München. (all genders welcome) Sie arbeiten in einem interdisziplinären und internationalen Umfeld und tragen durch Ihr Wissen und Ihre Expertise dazu bei, die vielfältigen regulatorischen Anforderungen im Bereich CMC zu erfassen, zu evaluieren [...]